Coherent, Zeiss Eye PDT Market Opportunity Pending Visudyne NDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Coherent, Inc. and Zeiss Humphrey Systems are preparing to compete head-to-head for the placement of photodynamic therapy (PDT) lasers to perform "wet" age-related macular degeneration (AMD) therapy in conjunction with QLT PhotoTherapeutics' Visudyne (verteporfin for injection) pending imminent FDA approval for the combined drug/device treatment.